| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/01/1993 | EP0557876A1 Use of xanthine derivatives for the treatment of muscle damage subsequent to complete interruption of blood circulation |
| 09/01/1993 | EP0557843A2 Sulfonylbenzyl-substituted pyridones as pharmaceuticals |
| 09/01/1993 | EP0557842A2 Sulphonylbenzyl substituted imidazolylpropenic acid derivatives |
| 09/01/1993 | EP0557787A1 Imidazolylphenol derivatives, medicaments containing them and a process for the preparation of these compounds and medicaments |
| 09/01/1993 | EP0557708A1 Medicament containing lipoic acid and panthothenic acid |
| 09/01/1993 | EP0557670A1 Pellets containing minocyclin |
| 09/01/1993 | EP0557497A1 NEW $g(b)-CARBOLIN DERIVATIVES, THEIR PREPARATION AND THEIR USE IN DRUGS |
| 09/01/1993 | EP0557408A1 Imidazolidinone compounds |
| 09/01/1993 | EP0557406A1 Gamma-turn peptidomimetics as fibrinogen antagonists |
| 09/01/1993 | EP0557404A1 ANTIVIRAL USE OF A 2,6-DI-t-BUTYLPHENOL COMPOUND SUBSTITUTED IN POSITION 4, PARTICULARLY IN RELATION TO HERPESVIRUSES AND PAPILLOMAVIRUSES. |
| 09/01/1993 | EP0557385A1 Topical compositions for transdermal delivery of produg derivatives of morphine |
| 09/01/1993 | EP0557383A1 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 09/01/1993 | EP0557375A1 New heterocyclic compounds as antagonists of excitatory amino acid receptors, processes for their preparation and their use |
| 09/01/1993 | EP0557348A1 Avermectins and milbemycins to treat parasitic in dogs |
| 09/01/1993 | EP0557347A1 Combinations of anthelmintically active agents |
| 09/01/1993 | EP0557336A1 Use of 2h-1,2,4-benzothiadiazine-3(4h)-thion-1,1-dioxides as antiviral medicaments. |
| 09/01/1993 | EP0557290A1 Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss |
| 09/01/1993 | EP0456764B1 Fat emulsion for endotracheal application, its production and use |
| 09/01/1993 | EP0316438B1 Chemical prevention or reversal of cataract by phase separation inhibitors |
| 09/01/1993 | CN1075722A Steroid, preparing processing, intermediate and application |
| 09/01/1993 | CN1075720A Biphenyl-substituted quinoline derivatives |
| 09/01/1993 | CN1075717A Benzodiazepine derivatives |
| 09/01/1993 | CN1075714A Alpha-aryl-alpha-hydroxy-beta-imidazolinyl-propionamides |
| 09/01/1993 | CN1075634A Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a prostaglandin or prostaglandin derivative |
| 09/01/1993 | CN1075633A Liposomal piroxicam formulations |
| 09/01/1993 | CN1075632A Alkoxylated phenyl and coumarin derivatives and application thereof |
| 09/01/1993 | CN1075631A Drug with the effect of resisting and preventing tension and intelligence-promoting |
| 09/01/1993 | CN1021969C Sialosylcerebrosioles and preparation method thereof |
| 09/01/1993 | CN1021967C Ouinoline derivatives and processes for preparation thereof |
| 08/31/1993 | US5241084 Protecting 10-hydroxy group by esterification, activating 7-hydroxy group by forming thiocarbonyl ester, deoxygenating, deprotecting |
| 08/31/1993 | US5241065 Selectively antagonize dopamine D-1 receptors |
| 08/31/1993 | US5240962 Alkyl or alkenyl-phenols |
| 08/31/1993 | US5240961 Administering L-carnitine or gamma-butyrobetaine |
| 08/31/1993 | US5240960 Antiinflammatory agents |
| 08/31/1993 | US5240959 Aranorosinol-a and aranorosinol-b produced by pseudoarachniotus roseus |
| 08/31/1993 | US5240958 Treating rheumatoid arthritis, promoting wound healing |
| 08/31/1993 | US5240954 Medicaments |
| 08/31/1993 | US5240953 Substituted triazoles as angiotensin ii inhibitors |
| 08/31/1993 | US5240950 Carbazate derivatives, their production and use |
| 08/31/1993 | US5240946 ((2-(amino-3,4-dioxo-1-cyclobuten-1-yl)amino)alkyl)-acid derivatives |
| 08/31/1993 | US5240945 Method and compositions for treating acne |
| 08/31/1993 | US5240943 Benzopyran class iii antiarrhythmic agents |
| 08/31/1993 | US5240941 Thioxo quinoline compounds, composition and method of use |
| 08/31/1993 | US5240939 Nitrogen bridge tetrahydroisoquinolines |
| 08/31/1993 | US5240938 Angiotensin II antagonists incorporating a substituted pyridoimidazolyl ring |
| 08/31/1993 | US5240936 Administering 3,4-dimethyl-9-ketoacridine |
| 08/31/1993 | US5240933 14-hydroxy-n-(2-methoxyethyl)-7,8-dihydromorphine and -norisomorphine, processes for the preparation thereof and the use thereof as pharmaceutical compositions |
| 08/31/1993 | US5240932 Percutaneously absorbable compositions of morphine or analogous analgesics of morphine |
| 08/31/1993 | US5240930 Pharmaceutical compositions for treatment of depression and low blood pressure |
| 08/31/1993 | US5240929 Lipoxygenase inhibitors |
| 08/31/1993 | US5240927 Benzo[β]thiophen-3-yl piperazines as antipsychotic agents |
| 08/31/1993 | US5240923 Treating glaucoma |
| 08/31/1993 | US5240922 Fertility enhancement |
| 08/31/1993 | US5240921 Cyclic pyridine-2,4- and -2,5-dicarboxylic acid diamides, processes for their preparation and their use |
| 08/31/1993 | US5240919 Benzthiazolinonyl-substituted alkylamides |
| 08/31/1993 | US5240917 Suppression of thromboxane levels by percutaneous administration of aspirin |
| 08/31/1993 | US5240914 Administering conjugate of glucuronic acid and (di)thiocarbamate |
| 08/31/1993 | US5240712 Therapeutic agents |
| 08/31/1993 | US5240711 Transdermal therapeutic system comprising as active component buprenorphine |
| 08/31/1993 | US5240702 Injecting solution of ethyleneoxide-propyleneoxide copolymer surfactant with fibrinolytic enzyme; lysing blood clots |
| 08/31/1993 | US5240701 Method of performing angioplasty procedures |
| 08/31/1993 | US5240700 Side effect reduction; prevention liver damage |
| 08/31/1993 | US5240696 Treatment of periodontitis |
| 08/31/1993 | US5240662 Process for the preparation of solid pharmaceutical compositions |
| 08/31/1993 | CA1321849C Adhesive compositions, controlled release compositions and transdermal drug delivery device |
| 08/31/1993 | CA1321793C Bicyclic diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
| 08/31/1993 | CA1321792C Piperidine opioid antagonists |
| 08/31/1993 | CA1321791C Preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains |
| 08/31/1993 | CA1321788C Antitumor substance, process for preparing the same and anticancer agent containing the same |
| 08/31/1993 | CA1321764C Dna sequence to target proteins to the mammary gland for efficient secretion |
| 08/31/1993 | CA1321753C Method for inhibiting loss of cognitive functions employing an ace inhibitor |
| 08/31/1993 | CA1321752C Products containing gallopamil and prazosin |
| 08/31/1993 | CA1321751C Mechanism mediating ruminal stasis in ruminal lactic acidosis |
| 08/31/1993 | CA1321748C Antifungal compositions and method of controlling myotic infections |
| 08/31/1993 | CA1321747C Antimicrobial for in-vitro diagnostic kits |
| 08/29/1993 | CA2090743A1 Pharmaceutical compounds |
| 08/29/1993 | CA2090548A1 Tetrahydrothiophene derivatives |
| 08/29/1993 | CA2090283A1 Phenoxyacetic acid derivatives |
| 08/29/1993 | CA2090097A1 Bu-4641v, an antibacterial, antiviral and antitumor antibiotic |
| 08/28/1993 | CA2090772A1 Chelate complexes and processes for their preparation |
| 08/28/1993 | CA2090281A1 Sulphonylbenzyl-substituted imidazolylpropenoic acid derivatives |
| 08/28/1993 | CA2090279A1 Sulphonylbenzyl-substituted imidazopyridines |
| 08/28/1993 | CA2090274A1 Sulphonylbenzyl-substituted imidazoles |
| 08/28/1993 | CA2090267A1 Sulphonylbenzyl-substituted pyridones |
| 08/27/1993 | WO1993017010A1 Benzodiazepinones and medicines containing them |
| 08/27/1993 | CA2106387A1 Benzodiazepinones |
| 08/27/1993 | CA2089707A1 Alkali metal 8,9-dehydroestrone sulfate esters |
| 08/26/1993 | DE4204922A1 Ketotricyclo(5.2.1.0)decan-derivate Ketotricyclo (5.2.1.0) decane derivatives |
| 08/26/1993 | CA2090156A1 Heterobicyclic compounds |
| 08/26/1993 | CA2089241A1 Process for preparing neotrehalose, and its uses |
| 08/25/1993 | EP0557244A1 Dosage forms having prolonged active-ingredient release |
| 08/25/1993 | EP0557171A1 Azaindoles, process for their preparation and medicines containing them |
| 08/25/1993 | EP0557118A1 The use of hyaluronic acid to repair ischemia reperfusion damage |
| 08/25/1993 | EP0557075A1 4H-naphtho 1,2-b pyran derivatives as antiproliferative agents |
| 08/25/1993 | EP0557065A1 Spheroid formulation |
| 08/25/1993 | EP0557064A1 Modified release formulation |
| 08/25/1993 | EP0557035A2 An ester cleavage process for use with beta-lactams |
| 08/25/1993 | EP0557016A1 Naphthalene derivatives, processes for preparing the same, and synthetic intermediates therefor |
| 08/25/1993 | EP0556947A1 Use of M1-selective antimuscarinic pyridobenzodiazepinones for the treatment and prevention of axial myopia |
| 08/25/1993 | EP0556880A2 Medical use for atypical beta-adrenoceptor agonists |